Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$47.5M |
| 2 |
Johnson & Johnson
JNJ
|
+$34.9M |
| 3 |
Phillips 66
PSX
|
+$34.7M |
| 4 |
Chevron
CVX
|
+$31.9M |
| 5 |
Johnson Controls International
JCI
|
+$31.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COUP
Coupa Software Incorporated
COUP
|
+$51.8M |
| 2 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$49.5M |
| 3 |
EVOP
EVO Payments, Inc. Class A Common Stock
EVOP
|
+$48.2M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$37.7M |
| 5 |
STOR
STORE Capital Corporation
STOR
|
+$23.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.69% |
| 2 | Industrials | 11.81% |
| 3 | Healthcare | 11.19% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Oaktree Specialty Lending
OCSL
$1.16B
| $964K | 0.01% |
+51,341
| New | +$1.02M |
|
1227
CALL
ConocoPhillips
COP
$160B
| $963K | 0.01% |
9,700
+900
| +10% | +$98.5K |
|
1228
PUT
Paychex
PAYX
$44.8B
| $961K | 0.01% |
+8,400
| New | +$956K |
|
1229
Rocket Companies
RKT
$39.9B
| $960K | 0.01% |
105,986
-206,105
| -66% | -$1.78M |
|
1230
JFrog
FROG
$11.1B
| $957K | 0.01% |
48,554
-1,673
| -3% | -$37.3K |
|
1231
PUT
Boston Scientific
BSX
$71B
| $955K | 0.01% |
+19,100
| New | +$900K |
|
|
VISN
1232
Vistance Networks Inc
VISN
$2.5B
| $955K | 0.01% |
149,926
-207,657
| -58% | -$1.57M |
|
1233
Harmonic Inc
HLIT
$1.31B
| $954K | 0.01% |
65,376
-198,105
| -75% | -$2.73M |
|
1234
PUT
Boston Beer
SAM
$1.95B
| $954K | 0.01% |
2,900
+1,900
| +190% | +$653K |
|
1235
Newmark Group
NMRK
$2.91B
| $953K | 0.01% |
134,665
+45,743
| +51% | +$367K |
|
1236
MBIA
MBI
$250M
| $950K | 0.01% |
102,583
-13,731
| -12% | -$164K |
|
1237
CALL
American Airlines Group
AAL
$9.02B
| $946K | 0.01% |
+64,100
| New | +$999K |
|
1238
Rogers Corp
ROG
$2.19B
| $943K | 0.01% |
+5,767
| New | +$832K |
|
|
SASR
1239
DELISTED
Sandy Spring Bancorp Inc
SASR
| $940K | 0.01% |
36,167
+9,176
| +34% | +$295K |
|
1240
CALL
MarketAxess Holdings
MKTX
$5.72B
| $938K | 0.01% |
2,400
-500
| -17% | -$177K |
|
1241
CALL
Super Micro Computer
SMCI
$22.8B
| $938K | 0.01% |
88,000
+20,000
| +29% | +$180K |
|
1242
PUT
Alcoa
AA
$13B
| $935K | 0.01% |
22,000
+15,800
| +255% | +$762K |
|
1243
PUT
Quest Diagnostics
DGX
$26.9B
| $934K | 0.01% |
6,600
+2,500
| +61% | +$358K |
|
1244
SFL Corp
SFL
$1.63B
| $934K | 0.01% |
98,324
+49,499
| +101% | +$489K |
|
|
KYNB
1245
Kyntra Bio
KYNB
$32.3M
| $933K | 0.01% |
+2,000
| New | +$1.06M |
|
1246
CALL
Murphy USA
MUSA
$10.4B
| $929K | 0.01% |
+3,600
| New | +$937K |
|
1247
CBRE Group
CBRE
$44B
| $928K | 0.01% |
12,739
+6,279
| +97% | +$513K |
|
1248
LivePerson
LPSN
$33.2M
| $928K | 0.01% |
14,036
-605
| -4% | -$97K |
|
1249
PUT
Royal Caribbean
RCL
$78.4B
| $927K | 0.01% |
14,200
+2,700
| +23% | +$178K |
|
1250
CALL
Mercado Libre
MELI
$98.8B
| $924K | 0.01% |
700
+100
| +17% | +$114K |
|
Similar funds
Paul Tudor Jones's Q1 2023 Portfolio in Review
As of Q1 2023, Paul Tudor Jones held 3,136 positions worth $6.46B, up 28% from $5.06B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
Paul Tudor Jones deployed $1.28B of net new capital in Q1 2023, opening 836 new positions and adding to 737 existing holdings. Its largest new stake was Johnson & Johnson: 216,183 shares worth $33.5M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $37.7M trimmed.
- Paul Tudor Jones's largest Q1 2023 buy was Johnson & Johnson: 216,183 shares worth $33.5M.
- Paul Tudor Jones added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $47.5M increase.
- Paul Tudor Jones's biggest Q1 2023 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $37.7M.
- Paul Tudor Jones fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $51.8M.
- Paul Tudor Jones's ten largest holdings make up 6.8% of its $6.46B portfolio in Q1 2023.
- Paul Tudor Jones opened 836 new positions and closed 800 in Q1 2023.
- Paul Tudor Jones's portfolio value rose 28% quarter-over-quarter to $6.46B.
Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.